Skip to content

Clinical trials

Phase 3 Vulvar Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Phase: Phase 3 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20051
20073
20092
20101
20112
20172
20181
20203
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated2
Active, not recruiting1
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC6
Gynecologic Oncology Group5
Shanghai Bovax Biotechnology Co., Ltd.4
Alliance for Clinical Trials in Oncology2
Beijing Health Guard Biotechnology, Inc1
INSYS Therapeutics Inc1
Institut Claudius Regaud1
Institut de Cancérologie de Lorraine1
Queensland Centre for Gynaecological Cancer1
University Magna Graecia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms23
Uterine Cervical Neoplasms16
Vaginal Neoplasms14
Condylomata Acuminata10
Papillomavirus Infections8
Endometrial Neoplasms4
Anus Neoplasms3
Breast Neoplasms3
Fallopian Tube Neoplasms3
Carcinoma, Ovarian Epithelial2

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.